This website requires Javascript for some parts to function propertly. Your experience may vary.

Hengeler Mueller advises BICO on the sale of Nanoscribe | Hengeler Mueller News

Hengeler Mueller advises BICO on the sale of Nanoscribe

BICO has reached an agreement to sell Nanoscribe to LAB14 GmbH. BICO is a laboratory automation partner and provider of selected workflows to the pharmaceutical and biotechnology industries. With 46,000+ instruments installed in over 65 countries, BICO products, software, and solutions are found in more than 3,500 laboratories. Operating through three business areas – Lab Automation, Life Science Solutions, and Bioprinting – BICO strives towards the vision to enable and automate the life science lab of the future. BICO is listed on Mid-Cap, Nasdaq Stockholm under BICO. Nanoscribe is a high-precision 3D printing technology company, specializing in two photon polymerization (2PP).

 

Hengeler Mueller team for BICO

M&A: Clemens Höhn (partner, lead, Berlin), Christoph Roth (senior associate, Munich), Moritz Evertz (senior associate, Düsseldorf), Felix Schwalm (associate, Berlin),

IP/IT: Matthias Rothkopf (counsel), Johannes Jäkle (associate, both Düsseldorf),

Public law/FDI: Jan D. Bonhage (partner), Nikolaus Wallraf (associate, both Berlin),

Antitrust: Christian Dankerl (counsel, Brüssel),

Tax: Markus Ernst (partner), Tim Würstlin (senior associate), Florian Lenhart (associate, all Munich),

Employment: Sonnhild Draack (counsel, Frankfurt).

Latest Articles

Hengeler Mueller advises BAWAG on successful closing of the acquisition of the German retail business from Barclays

Hengeler Mueller advises METRO on Delisting

Hengeler Mueller advises Paragon Partners on acquisition of DYMATRIX

Recent Mergers & Acquisitions Work